[Elsevier] Review on 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020 Emphasizing Intellectual Property and Regulatory Considerations for Reformulations and New Combinations

sonupawar Post time 2024-6-14 13:09:14 | Show all posts |Read mode
Reward10points

journal:Journal of Pharmaceutical Sciences

Authors:Jyosna Devi Ravula; Ramakrishna Nirogi; Manthan D. Janodia

Published date:2023-8-

DOI:10.1016/j.xphs.2023.04.004

PDF link:https://www.sciencedirect.com/sc ... 022354923001508/pdf

Article link:http://dx.doi.org/10.1016/j.xphs.2023.04.004

Article Source:Elsevier BV


Remark:

Best Answer

Reply

Use magic Donate Report

All Reply1 Show all posts
rizwan.bajwas Post time 2024-6-14 13:09:15 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    40

Latest Reply

Return to the list